Form 4: Edwards Lifesciences CEO Bernard J. Zovighian Reports Changes in Beneficial Ownership
SEC Form 4 Filing
CEO Bernard J. Zovighian reports changes in his beneficial ownership of Edwards Lifesciences Corp stock due to tax withholding and a gift.
Summary
- On May 11, 2025, Bernard J. Zovighian, CEO of Edwards Lifesciences, had 2,860 shares of common stock disposed of to cover tax obligations at a price of $73.68 per share, leaving him with 89,562.5511 directly owned shares.
- On May 13, 2025, Zovighian gifted 2,771 shares of common stock, reducing his direct ownership to 86,791.5511 shares.
- On May 13, 2025, Zovighian acquired 2,771 shares of common stock through a gift, increasing his indirect ownership to 19,847 shares held by trust.
- He also indirectly owns 3,605.8487 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing changes in stock ownership, which is neutral in sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- Shareholders are informed about the CEO's stock transactions.
Key Dates
| Date | Description |
|---|---|
| 05/11/2025 | Disposition of 2,860 shares for tax withholding. |
| 05/13/2025 | Gift of 2,771 shares. |
| 05/13/2025 | Filing date of the Form 4. |
Keywords
beneficial ownership, Form 4, Edwards Lifesciences, Zovighian, stock, CEO, transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.